|
right The Therapeutic Goods Administration (TGA) is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia.〔(【引用サイトリンク】title=About the TGA )〕 It is a Division of the Australian Department of Health established under the ''Therapeutic Goods Act 1989 (Cth)''.〔(【引用サイトリンク】title=About the Australina therapeutic goods legislation )〕〔(''Therapeutic Goods Act 1999'' (Cth) )〕 The TGA is responsible for conducting assessment and monitoring activities to ensure that therapeutic goods available in Australia are of an acceptable standard and that access to therapeutic advances is in a timely manner. == TGA Expert Advisory Committees == The TGA has nine statutory expert committees it may call upon to obtain independent advice on scientific and technical matters, including: * Advisory Committee on Biologicals (ACB) * Advisory Committee on Complementary Medicines (ACCM) * Advisory Committee on Medical Devices (ACMD) * Advisory Committee on Non-prescription Medicines (ACNM) * Advisory Committee on Prescription Medicines (ACPM) * Advisory Committee on the Safety of Medical Devices (ACSMD) * Advisory Committee on the Safety of Medicines (ACSOM) * Advisory Committee on the Safety of Vaccines (ACSOV) * Therapeutic Goods Committee (TGC) – advises the Minister on standards for therapeutic goods, including labelling and packaging, and on principles to be observed in the manufacture of therapeutic goods for use in humans. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Therapeutic Goods Administration」の詳細全文を読む スポンサード リンク
|
